119th Congress · introduced in the Senate · Sep 8, 2025
Kidney Care Access Protection Act
Official title from Congress.gov
Latest action (Sep 8, 2025): Read twice and referred to the Committee on Finance.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
66 citations; showing the 25 most recently posted.
U.S. RENAL CARE · lobbying firm or registrant: LESTER HEALTH LAW PLLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$45,000
Paid to lobbying firm
S. 2730, H.R. 6214 The Kidney Care Access Protection Act; ESRD PPS and QIP rulemaking; CMMI Kidney Care Choices model
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CORMEDIX INC. · lobbying firm or registrant: CORMEDIX INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 21, 2026 · issue area: Health Issues
$200,000
Spent on own lobbying
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Up…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FRESENIUS MEDICAL CARE NORTH AMERICA · lobbying firm or registrant: AVENUE SOLUTIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
…ronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney In…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DIALYSIS PATIENT CITIZENS · lobbying firm or registrant: DIALYSIS PATIENT CITIZENS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$200,000
Spent on own lobbying
…ney disease and home dialysis; Support H.R. 2199/S. 1173 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; and Support S. 2730/H.R. 6214 - The Kidney Care Access Protection Act which would ensure appropriate reimbursement for quality care and improve patient access to innovative drugs,…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KIDNEY CARE PARTNERS · lobbying firm or registrant: FEDERAL HEALTH POLICY STRATEGIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$80,000
Paid to lobbying firm
…ues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KIDNEY CARE PARTNERS · lobbying firm or registrant: FEDERAL HEALTH POLICY STRATEGIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$80,000
Paid to lobbying firm
…ues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN KIDNEY FUND · lobbying firm or registrant: AMERICAN KIDNEY FUND
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$220,000
Spent on own lobbying
…518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 CMS-1846-P: Medicare Program; CY 2027 Changes to the End-S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAVITA INC · lobbying firm or registrant: DAVITA INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$1,120,000
Spent on own lobbying
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) CMS regulations pertaining to the Medicare…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAVITA INC · lobbying firm or registrant: DAVITA INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$1,120,000
Spent on own lobbying
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) CMS regulations pertaining to the Medicare…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
RENAL HEALTHCARE ASSOCIATION · lobbying firm or registrant: MEHLMAN CONSULTING, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$70,000
Paid to lobbying firm
Issues related to End Stage Renal Disease, Acute Kidney Injury, Dialysis, and ESRD Treatment Choice Model. Telehealth. H.R. 6214/S. 2730 - Kidney Care Access Protection Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act. H.R. 8875 - Improving Home Dialysis Act of 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KIDNEY CARE PARTNERS · lobbying firm or registrant: CROSSROADS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 17, 2026 · issue area: Health Issues
$110,000
Paid to lobbying firm
…w to improve the quality of kidney care treatment, expand innovation, and other insurance/payment policies. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KIDNEY CARE PARTNERS · lobbying firm or registrant: CROSSROADS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 17, 2026 · issue area: Medicare/Medicaid
$110,000
Paid to lobbying firm
…payment system for end-stage renal disease (ESRD). Medicare coverage and reimbursement related to dialysis. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750). Improving Home Dialysis Act of 2026 (H.R.8875).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FRESENIUS MEDICAL CARE NORTH AMERICA · lobbying firm or registrant: FRESENIUS MEDICAL CARE NORTH AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Medicare/Medicaid
$1,000,000
Spent on own lobbying
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act H.R. 6214/S. 2730 - The Kidney Care Access Protection Act H.R. 8319 - KIDNEY Remote Monitoring Act H.R. 4582 H.R. 4583/ S.1552 - Living Donor Protection Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
U.S. RENAL CARE · lobbying firm or registrant: JEFFREY J. KIMBELL & ASSOCIATES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
…H.R.2199/S.1173; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis; Kidney Care Access Protection Act - H.R. 6214/S.2730
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN NEPHROLOGY NURSES ASSOCIATION · lobbying firm or registrant: VENABLE LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 14, 2026 · issue area: Health Issues
$30,000
Paid to lobbying firm
…Future Advancement of Academic Nursing Act (H.R. 6607 / S. 3435); Title VIII Reauthorization Act (H.R. 3593 / S. 1874); Kidney Care Protection Act (H.R. 6214 / S. 2730); Nursing is a Professional Degree Act (H.R. 8691 / S. 4568); Share Act (H.R. 2332); Promoting Access to Diabetic Shoes Act (H.R. 1616).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
U.S. RENAL CARE · lobbying firm or registrant: LESTER HEALTH LAW PLLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 10, 2026 · issue area: Medicare/Medicaid
$23,000
Paid to lobbying firm
S. 2730, H.R. 6214 The Kidney Care Access Protection Act; ESRD PPS and QIP rulemaking; CMMI Kidney Care Choices model
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CORMEDIX INC. · lobbying firm or registrant: CORMEDIX INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 31, 2026 · issue area: Health Issues
$220,000
Spent on own lobbying
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Up…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AKEBIA THERAPEUTICS, INC. · lobbying firm or registrant: AKEBIA THERAPEUTICS, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$360,000
Spent on own lobbying
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 6214, Kidney Care Access Protection Act S. 2730, Kidney Care Access Protection Act Implementation of P.L. 118-14, Continuing Appropriations Act, 2024 and Other Extensions Act, including provisions related to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DIALYSIS PATIENT CITIZENS · lobbying firm or registrant: DIALYSIS PATIENT CITIZENS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$500,000
Spent on own lobbying
…ney disease and home dialysis; Support H.R. 2199/S. 1173 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; and Support S. 2730/H.R. 6214 - The Kidney Care Access Protection Act which would ensure appropriate reimbursement for quality care and improve patient access to innovative drugs,…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN KIDNEY FUND · lobbying firm or registrant: AMERICAN KIDNEY FUND
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$240,000
Spent on own lobbying
…518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 Medicare Program; Contract Year 2027 Policy and Technical…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAVITA INC · lobbying firm or registrant: DAVITA INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$980,000
Spent on own lobbying
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS re…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAVITA INC · lobbying firm or registrant: DAVITA INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$980,000
Spent on own lobbying
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS re…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FRESENIUS MEDICAL CARE NORTH AMERICA · lobbying firm or registrant: AVENUE SOLUTIONS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
…ronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KIDNEY CARE PARTNERS · lobbying firm or registrant: FEDERAL HEALTH POLICY STRATEGIES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$80,000
Paid to lobbying firm
…ues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KIDNEY CARE PARTNERS · lobbying firm or registrant: FEDERAL HEALTH POLICY STRATEGIES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$80,000
Paid to lobbying firm
…ues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing